BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Bio NC

  Metabolon Awarded US Patent for Metabolic Biomarkers of Efficacy of Peroxisome Proliferator Activated Receptor (PPAR) Affecting Drugs

  October 20, 2010

   · 

  1 min read
• Drug Development

  CEL-SCI Receives Approval from Seven Hospital Institutional Review Boards in India to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  October 20, 2010

   · 

  1 min read
• Early Vasopressor Use in Trauma Linked to Increased Mortality Risk

  October 20, 2010

   · 

  1 min read
• Drug Development

  Pfizer Inc. Hormone, Prempro Almost Double Breast Cancer Death Risk in U.S. Research

  October 20, 2010

   · 

  1 min read
• Genetown

  Generex Biotechnology Corporation Common Stock to be Quoted on the OTCQB Under the Symbol ‘GNBT’ Beginning Thursday, October 21, 2010

  October 20, 2010

   · 

  6 min read
• Business

  MEDICREA: 2010 Third Quarter Sales and 2010 Half Year Results

  October 20, 2010

   · 

  1 min read
• Drug Development

  Quark Pharmaceuticals Inc. Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007

  October 20, 2010

   · 

  3 min read
• Business

  eResearch Technology Inc. (ERT) to Announce Third Quarter 2010 Results on November 4, 2010

  October 20, 2010

   · 

  2 min read
• Pharm Country

  Access Pharmaceuticals Files Additional IP For Cobalamin Oral Delivery Technology

  October 20, 2010

   · 

  4 min read
• Business

  ProChon Biotech Ltd. Names Dr. Jack Farr to Scientific Advisory Board

  October 20, 2010

   · 

  1 min read